<us-patent-grant lang="EN" dtd-version="v4.2 2006-08-23" file="US07296566-20071120.XML" status="PRODUCTION" id="us-patent-grant" country="US" date-produced="20071106" date-publ="20071120">
<us-bibliographic-data-grant>
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07296566</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<application-reference appl-type="utility">
<document-id>
<country>US</country>
<doc-number>10138133</doc-number>
<date>20020502</date>
</document-id>
</application-reference>
<us-application-series-code>10</us-application-series-code>
<us-term-of-grant>
<us-term-extension>177</us-term-extension>
</us-term-of-grant>
<classifications-ipcr>
<classification-ipcr>
<ipc-version-indicator><date>20060101</date></ipc-version-indicator>
<classification-level>A</classification-level>
<section>A</section>
<class>61</class>
<subclass>M</subclass>
<main-group>11</main-group>
<subgroup>00</subgroup>
<symbol-position>F</symbol-position>
<classification-value>I</classification-value>
<action-date><date>20071120</date></action-date>
<generating-office><country>US</country></generating-office>
<classification-status>B</classification-status>
<classification-data-source>H</classification-data-source>
</classification-ipcr>
</classifications-ipcr>
<classification-national>
<country>US</country>
<main-classification>12820014</main-classification>
<further-classification>12820022</further-classification>
</classification-national>
<invention-title id="d0e53">Nasal delivery device including spray nozzle</invention-title>
<references-cited>
<citation>
<patcit num="00001">
<document-id>
<country>US</country>
<doc-number>3373743</doc-number>
<kind>A</kind>
<name>Saffir</name>
<date>19680300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>128218</main-classification></classification-national>
</citation>
<citation>
<patcit num="00002">
<document-id>
<country>US</country>
<doc-number>3874380</doc-number>
<kind>A</kind>
<name>Baum</name>
<date>19750400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>128206</main-classification></classification-national>
</citation>
<citation>
<patcit num="00003">
<document-id>
<country>US</country>
<doc-number>3889351</doc-number>
<kind>A</kind>
<name>Tischlinger</name>
<date>19750600</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification> 29447</main-classification></classification-national>
</citation>
<citation>
<patcit num="00004">
<document-id>
<country>US</country>
<doc-number>3987940</doc-number>
<kind>A</kind>
<name>Tischlinger</name>
<date>19761000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>222386</main-classification></classification-national>
</citation>
<citation>
<patcit num="00005">
<document-id>
<country>US</country>
<doc-number>4245654</doc-number>
<kind>A</kind>
<name>Raitto</name>
<date>19810100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>128765</main-classification></classification-national>
</citation>
<citation>
<patcit num="00006">
<document-id>
<country>US</country>
<doc-number>4344573</doc-number>
<kind>A</kind>
<name>De Felice</name>
<date>19820800</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239320</main-classification></classification-national>
</citation>
<citation>
<patcit num="00007">
<document-id>
<country>US</country>
<doc-number>4444335</doc-number>
<kind>A</kind>
<name>Wood et al.</name>
<date>19840400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification> 22 43</main-classification></classification-national>
</citation>
<citation>
<patcit num="00008">
<document-id>
<country>US</country>
<doc-number>4493348</doc-number>
<kind>A</kind>
<name>Lemmons</name>
<date>19850100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>141  1</main-classification></classification-national>
</citation>
<citation>
<patcit num="00009">
<document-id>
<country>US</country>
<doc-number>4513891</doc-number>
<kind>A</kind>
<name>Hain et al.</name>
<date>19850400</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>222213</main-classification></classification-national>
</citation>
<citation>
<patcit num="00010">
<document-id>
<country>US</country>
<doc-number>4718463</doc-number>
<kind>A</kind>
<name>Jurgens, Jr. et al.</name>
<date>19880100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>141 11</main-classification></classification-national>
</citation>
<citation>
<patcit num="00011">
<document-id>
<country>US</country>
<doc-number>4767416</doc-number>
<kind>A</kind>
<name>Wolf et al.</name>
<date>19880800</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604239</main-classification></classification-national>
</citation>
<citation>
<patcit num="00012">
<document-id>
<country>US</country>
<doc-number>4790832</doc-number>
<kind>A</kind>
<name>Lopez</name>
<date>19881200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604283</main-classification></classification-national>
</citation>
<citation>
<patcit num="00013">
<document-id>
<country>US</country>
<doc-number>4801093</doc-number>
<kind>A</kind>
<name>Brunet et al.</name>
<date>19890100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>239490</main-classification></classification-national>
</citation>
<citation>
<patcit num="00014">
<document-id>
<country>US</country>
<doc-number>4895559</doc-number>
<kind>A</kind>
<name>Shippert</name>
<date>19900100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604 15</main-classification></classification-national>
</citation>
<citation>
<patcit num="00015">
<document-id>
<country>US</country>
<doc-number>4919167</doc-number>
<kind>A</kind>
<name>Manska</name>
<date>19900400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>137512</main-classification></classification-national>
</citation>
<citation>
<patcit num="00016">
<document-id>
<country>US</country>
<doc-number>4923448</doc-number>
<kind>A</kind>
<name>Ennis, III</name>
<date>19900500</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604239</main-classification></classification-national>
</citation>
<citation>
<patcit num="00017">
<document-id>
<country>US</country>
<doc-number>4929230</doc-number>
<kind>A</kind>
<name>Pfleger</name>
<date>19900500</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604 90</main-classification></classification-national>
</citation>
<citation>
<patcit num="00018">
<document-id>
<country>US</country>
<doc-number>4946069</doc-number>
<kind>A</kind>
<name>Fuchs</name>
<date>19900800</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>222 43</main-classification></classification-national>
</citation>
<citation>
<patcit num="00019">
<document-id>
<country>US</country>
<doc-number>5064122</doc-number>
<kind>A</kind>
<name>Kamishita et al.</name>
<date>19911100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>239396</main-classification></classification-national>
</citation>
<citation>
<patcit num="00020">
<document-id>
<country>US</country>
<doc-number>5098405</doc-number>
<kind>A</kind>
<name>Peterson et al.</name>
<date>19920300</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604247</main-classification></classification-national>
</citation>
<citation>
<patcit num="00021">
<document-id>
<country>US</country>
<doc-number>5152752</doc-number>
<kind>A</kind>
<name>Hammami</name>
<date>19921000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604110</main-classification></classification-national>
</citation>
<citation>
<patcit num="00022">
<document-id>
<country>US</country>
<doc-number>5181658</doc-number>
<kind>A</kind>
<name>Behar</name>
<date>19930100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>239493</main-classification></classification-national>
</citation>
<citation>
<patcit num="00023">
<document-id>
<country>US</country>
<doc-number>5257726</doc-number>
<kind>A</kind>
<name>Graf et al.</name>
<date>19931100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>222320</main-classification></classification-national>
</citation>
<citation>
<patcit num="00024">
<document-id>
<country>US</country>
<doc-number>5265154</doc-number>
<kind>A</kind>
<name>Schotz</name>
<date>19931100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>379102</main-classification></classification-national>
</citation>
<citation>
<patcit num="00025">
<document-id>
<country>US</country>
<doc-number>5287983</doc-number>
<kind>A</kind>
<name>Reil et al.</name>
<date>19940200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>220258</main-classification></classification-national>
</citation>
<citation>
<patcit num="00026">
<document-id>
<country>US</country>
<doc-number>5328099</doc-number>
<kind>A</kind>
<name>Petit et al.</name>
<date>19940700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>239372</main-classification></classification-national>
</citation>
<citation>
<patcit num="00027">
<document-id>
<country>US</country>
<doc-number>5373684</doc-number>
<kind>A</kind>
<name>Vacca</name>
<date>19941200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification> 53425</main-classification></classification-national>
</citation>
<citation>
<patcit num="00028">
<document-id>
<country>US</country>
<doc-number>5509578</doc-number>
<kind>A</kind>
<name>Livingstone</name>
<date>19960400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>222 82</main-classification></classification-national>
</citation>
<citation>
<patcit num="00029">
<document-id>
<country>US</country>
<doc-number>5519984</doc-number>
<kind>A</kind>
<name>Beussink et al.</name>
<date>19960500</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification> 53489</main-classification></classification-national>
</citation>
<citation>
<patcit num="00030">
<document-id>
<country>US</country>
<doc-number>5531255</doc-number>
<kind>A</kind>
<name>Vacca</name>
<date>19960700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>141285</main-classification></classification-national>
</citation>
<citation>
<patcit num="00031">
<document-id>
<country>US</country>
<doc-number>5537042</doc-number>
<kind>A</kind>
<name>Beutler et al.</name>
<date>19960700</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>324432</main-classification></classification-national>
</citation>
<citation>
<patcit num="00032">
<document-id>
<country>US</country>
<doc-number>5597530</doc-number>
<kind>A</kind>
<name>Smith et al.</name>
<date>19970100</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>422 28</main-classification></classification-national>
</citation>
<citation>
<patcit num="00033">
<document-id>
<country>US</country>
<doc-number>5601077</doc-number>
<kind>A</kind>
<name>Imbert</name>
<date>19970200</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>12820014</main-classification></classification-national>
</citation>
<citation>
<patcit num="00034">
<document-id>
<country>US</country>
<doc-number>5620425</doc-number>
<kind>A</kind>
<name>Heffernan et al.</name>
<date>19970400</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604281</main-classification></classification-national>
</citation>
<citation>
<patcit num="00035">
<document-id>
<country>US</country>
<doc-number>5901942</doc-number>
<kind>A</kind>
<name>Lopez</name>
<date>19990500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>2511491</main-classification></classification-national>
</citation>
<citation>
<patcit num="00036">
<document-id>
<country>US</country>
<doc-number>5961489</doc-number>
<kind>A</kind>
<name>Hirota</name>
<date>19991000</date>
</document-id>
</patcit>
<category>cited by other</category>
<classification-national><country>US</country><main-classification>604 94</main-classification></classification-national>
</citation>
<citation>
<patcit num="00037">
<document-id>
<country>US</country>
<doc-number>6041775</doc-number>
<kind>A</kind>
<name>Century</name>
<date>20000300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820014</main-classification></classification-national>
</citation>
<citation>
<patcit num="00038">
<document-id>
<country>US</country>
<doc-number>6112743</doc-number>
<kind>A</kind>
<name>Denton</name>
<date>20000900</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820014</main-classification></classification-national>
</citation>
<citation>
<patcit num="00039">
<document-id>
<country>US</country>
<doc-number>6161731</doc-number>
<kind>A</kind>
<name>Sigg</name>
<date>20001200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>222158</main-classification></classification-national>
</citation>
<citation>
<patcit num="00040">
<document-id>
<country>US</country>
<doc-number>6382204</doc-number>
<kind>B1</kind>
<name>Jansen et al.</name>
<date>20020500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820019</main-classification></classification-national>
</citation>
<citation>
<patcit num="00041">
<document-id>
<country>US</country>
<doc-number>6530371</doc-number>
<kind>B2</kind>
<name>Jansen et al.</name>
<date>20030300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820019</main-classification></classification-national>
</citation>
<citation>
<patcit num="00042">
<document-id>
<country>US</country>
<doc-number>6622721</doc-number>
<kind>B2</kind>
<name>Vedrine et al.</name>
<date>20030900</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820019</main-classification></classification-national>
</citation>
<citation>
<patcit num="00043">
<document-id>
<country>US</country>
<doc-number>6705493</doc-number>
<kind>B1</kind>
<name>Mijers</name>
<date>20040300</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>2223217</main-classification></classification-national>
</citation>
<citation>
<patcit num="00044">
<document-id>
<country>US</country>
<doc-number>6761286</doc-number>
<kind>B2</kind>
<name>Py et al.</name>
<date>20040700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>222105</main-classification></classification-national>
</citation>
<citation>
<patcit num="00045">
<document-id>
<country>US</country>
<doc-number>6789750</doc-number>
<kind>B1</kind>
<name>Heldt</name>
<date>20040900</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239490</main-classification></classification-national>
</citation>
<citation>
<patcit num="00046">
<document-id>
<country>US</country>
<doc-number>7021561</doc-number>
<kind>B2</kind>
<name>Vedrine et al.</name>
<date>20060400</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239329</main-classification></classification-national>
</citation>
<citation>
<patcit num="00047">
<document-id>
<country>US</country>
<doc-number>7044125</doc-number>
<kind>B2</kind>
<name>Vedrine et al.</name>
<date>20060500</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820019</main-classification></classification-national>
</citation>
<citation>
<patcit num="00048">
<document-id>
<country>US</country>
<doc-number>7182277</doc-number>
<kind>B2</kind>
<name>Vedrine et al.</name>
<date>20070200</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239329</main-classification></classification-national>
</citation>
<citation>
<patcit num="00049">
<document-id>
<country>US</country>
<doc-number>2002/0010428</doc-number>
<kind>A1</kind>
<name>Vedrine et al.</name>
<date>20020100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>604187</main-classification></classification-national>
</citation>
<citation>
<patcit num="00050">
<document-id>
<country>US</country>
<doc-number>2002/0174865</doc-number>
<kind>A1</kind>
<name>Gatton et al.</name>
<date>20021100</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>12820018</main-classification></classification-national>
</citation>
<citation>
<patcit num="00051">
<document-id>
<country>US</country>
<doc-number>2003/0111552</doc-number>
<kind>A1</kind>
<name>Vedrine et al.</name>
<date>20030600</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239329</main-classification></classification-national>
</citation>
<citation>
<patcit num="00052">
<document-id>
<country>US</country>
<doc-number>2006/0124778</doc-number>
<kind>A1</kind>
<name>Vendrine et al.</name>
<date>20060600</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239602</main-classification></classification-national>
</citation>
<citation>
<patcit num="00053">
<document-id>
<country>US</country>
<doc-number>2006/0151629</doc-number>
<kind>A1</kind>
<name>Vedrine et al.</name>
<date>20060700</date>
</document-id>
</patcit>
<category>cited by examiner</category>
<classification-national><country>US</country><main-classification>239329</main-classification></classification-national>
</citation>
<citation>
<patcit num="00054">
<document-id>
<country>EP</country>
<doc-number>0334349</doc-number>
<date>19890300</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00055">
<document-id>
<country>EP</country>
<doc-number>0 546 607</doc-number>
<kind>B1</kind>
<date>19980600</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00056">
<document-id>
<country>FR</country>
<doc-number>2635084</doc-number>
<date>19900900</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00057">
<document-id>
<country>FR</country>
<doc-number>2739294</doc-number>
<date>19950900</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
<citation>
<patcit num="00058">
<document-id>
<country>JP</country>
<doc-number>3047521</doc-number>
<date>19980100</date>
</document-id>
</patcit>
<category>cited by other</category>
</citation>
</references-cited>
<number-of-claims>5</number-of-claims>
<us-exemplary-claim>1</us-exemplary-claim>
<us-field-of-classification-search>
<classification-national>
<country>US</country>
<main-classification>12820014</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820118</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820022</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820312</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820019</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820021</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820023</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>12820718</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222158</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222153</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>22240211</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>22240213</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222182</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222542</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222538</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222562</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222544</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222559</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>222541</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>239482</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>239483</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>239490</main-classification>
</classification-national>
<classification-national>
<country>US</country>
<main-classification>239491</main-classification>
</classification-national>
</us-field-of-classification-search>
<figures>
<number-of-drawing-sheets>4</number-of-drawing-sheets>
<number-of-figures>9</number-of-figures>
</figures>
<us-related-documents>
<continuation>
<relation>
<parent-doc>
<document-id>
<country>US</country>
<doc-number>09417345</doc-number>
<kind>00</kind>
<date>19991014</date>
</document-id>
<parent-status>ABANDONED</parent-status>
</parent-doc>
<child-doc>
<document-id>
<country>US</country>
<doc-number>10138133</doc-number>
</document-id>
</child-doc>
</relation>
</continuation>
<related-publication>
<document-id>
<country>US</country>
<doc-number>20030075168</doc-number>
<kind>A2</kind>
<date>20030424</date>
</document-id>
</related-publication>
</us-related-documents>
<parties>
<applicants>
<applicant sequence="001" app-type="applicant-inventor" designation="us-only">
<addressbook>
<last-name>Alchas</last-name>
<first-name>Paul G.</first-name>
<address>
<city>Wayne</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
<nationality>
<country>omitted</country>
</nationality>
<residence>
<country>US</country>
</residence>
</applicant>
</applicants>
<agents>
<agent sequence="01" rep-type="attorney">
<addressbook>
<last-name>Fortunato</last-name>
<first-name>David M.</first-name>
<address>
<country>unknown</country>
</address>
</addressbook>
</agent>
<agent sequence="02" rep-type="attorney">
<addressbook>
<orgname>Cohen Pontani Lieberman &amp; Pavane LLP</orgname>
<address>
<country>unknown</country>
</address>
</addressbook>
</agent>
</agents>
</parties>
<assignees>
<assignee>
<addressbook>
<orgname>Becton, Dickinson and Company</orgname>
<role>02</role>
<address>
<city>Franklin Lakes</city>
<state>NJ</state>
<country>US</country>
</address>
</addressbook>
</assignee>
</assignees>
<examiners>
<primary-examiner>
<last-name>Ho</last-name>
<first-name>(Jackie) Tan-Uyen</first-name>
<department>3731</department>
</primary-examiner>
<assistant-examiner>
<last-name>Erezo</last-name>
<first-name>Darwin P.</first-name>
</assistant-examiner>
</examiners>
</us-bibliographic-data-grant>
<abstract id="abstract">
<p id="p-0001" num="0000">A nasal delivery device is provided for delivering substances such as liquid drugs, vaccines and the like to a nasal passage. The nasal delivery device preferably comprises a drug container such as syringe and a separable spray nozzle. The spray nozzle includes a rigid plastic cap having a spray aperture at a distal end of the nozzle for delivering the liquid substance to the nasal passage. Attachment means is provided for attaching the spray nozzle to the syringe at the time of the delivery of the liquid substance to the nasal passage. The nozzle defines a conduit that allows fluid communication from the syringe to the spray aperture. The nozzle includes an internal valve between the spray aperture and the syringe for allowing only pressurized liquid substance to flow through the conduit and the aperture so that a mist or spray is delivered through the spray aperture.</p>
</abstract>
<drawings id="DRAWINGS">
<figure id="Fig-EMI-D00000" num="00000">
<img id="EMI-D00000" he="86.28mm" wi="297.52mm" file="US07296566-20071120-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00001" num="00001">
<img id="EMI-D00001" he="248.24mm" wi="161.37mm" file="US07296566-20071120-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00002" num="00002">
<img id="EMI-D00002" he="235.29mm" wi="159.00mm" file="US07296566-20071120-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00003" num="00003">
<img id="EMI-D00003" he="65.02mm" wi="144.10mm" file="US07296566-20071120-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
<figure id="Fig-EMI-D00004" num="00004">
<img id="EMI-D00004" he="193.21mm" wi="153.08mm" file="US07296566-20071120-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/>
</figure>
</drawings>
<description id="description">
<?RELAPP description="Other Patent Relations" end="lead"?>
<heading id="h-0001" level="1">CROSS-REFERENCE TO RELATED APPLICATIONS</heading>
<p id="p-0002" num="0001">This is a Continuation of U.S. application Ser. No. 09/417,345, filed on Oct. 14, 1999 now abandoned, the entire content of which is incorporated herein by reference.</p>
<?RELAPP description="Other Patent Relations" end="tail"?>
<?BRFSUM description="Brief Summary" end="lead"?>
<heading id="h-0002" level="1">FIELD OF THE INVENTION</heading>
<p id="p-0003" num="0002">The present invention generally relates to delivery systems for delivering substances such as drugs, vaccines and the like, and more specifically relates to a delivery device for delivering such substances intranasally, i.e., through the nose, including a spray nozzle for use with a prefilled drug container such as a syringe. In addition, the present invention relates to a nasal delivery device and more particularly to a removable spray nozzle for use with standard syringes.</p>
<heading id="h-0003" level="1">BACKGROUND OF THE INVENTION</heading>
<p id="p-0004" num="0003">Many injectable drugs are packaged and distributed in hypodermic syringes that will eventually be used to administer the drug to the patient. The syringe is the low cost, efficient, sterile instrument of choice for delivering liquid drug through a hypodermic needle. The hypodermic syringe also can be an excellent storage device for drug placed in it by a pharmaceutical manufacturer or hospital pharmacy.</p>
<p id="p-0005" num="0004">Syringes may also prove useful for distributing and administering drugs even where a hypodermic injection is not desired. Delivering a therapeutic liquid as a spray through the nasal passageway is preferred to deliver certain therapeutic liquids under certain conditions. There have been several proposed devices to make syringes useful as nasal sprayers.</p>
<p id="p-0006" num="0005">U.S. Pat. No. 5,601,077 to Imbert discloses a nasal syringe sprayer for discharging the liquid contents of the syringe in a spray through the nasal passages. However, the use of that device is limited to pre-stored, liquid stable drugs. That is, the sprayer of the patent cannot be used with drugs that need to be maintained in powder or lyophilized form and reconstituted just prior to intake. Additionally, the sprayer tip of that patent does not allow an individual to load the syringe with a liquid mediation from a standard vial since the nasal spray nozzle cannot be inserted into such vials to extract the contents of the vial for loading the syringe.</p>
<p id="p-0007" num="0006">U.S. Pat. No. 4,767,416 to Wolf et al. discloses a flexible, removable spray nozzle for a syringe. The spray nozzle may be attached directly to a luer fitting of a syringe or may be adapted to fit over and attached to a hypodermic needle secured to the luer fitting. In either case, the spray nozzle fits onto the syringe in order to prevent back flow and leakage of the liquid at the attachment of the spray nozzle to the syringe. One shortcoming of the device is that the nozzle does not prevent unpressurized liquid from flowing through the opening at the tip of the spray nozzle.</p>
<p id="p-0008" num="0007">In view of the shortcomings and drawbacks of currently available or proposed systems, it is desirable to provide a removable spray nozzle for use with hypodermic syringes that provides a leak-free seal and prevents unpressurized liquid from flowing out the opening at the spray nozzle.</p>
<heading id="h-0004" level="1">SUMMARY OF THE INVENTION</heading>
<p id="p-0009" num="0008">In contrast to the prior devices discussed above, it has been found that a nasal delivery device particularly suited for use in intranasally delivering substances such as drugs, vaccines and the like can be constructed in accordance with the present invention. Specifically, the invention is directed to a nasal delivery device having a removable spray nozzle adapted for delivering liquid substances such as a drug from a syringe to a nasal passage. The spray nozzle includes a plastic rigid cap having a spray aperture at one end of the nozzle for delivering the liquid substance to the nasal passage. The spray nozzle is attached to the syringe when delivery of the liquid substance will be sprayed into the nasal passage. The spray nozzle includes an internal valve that allows pressurized liquid substance to flow through the nozzle and out of the spray aperture while also preventing unpressurized liquid from flowing through the spray aperture.</p>
<p id="p-0010" num="0009">In the preferred embodiment, the spray nozzle has a flange at a proximal end to prevent an individual from over-inserting the nozzle into the nasal passage. The nozzle may also include a resilient, elongate sleeve extending from the nozzle that is received over an elongate barrel of the syringe. The elongate sleeve includes a flange at an end to aid a user in grasping the assembly and delivering the liquid from the syringe to the nasal passage.</p>
<p id="p-0011" num="0010">The various features and advantages of this invention will become apparent to those skilled in the art from the following detailed description of the currently preferred embodiments. The drawings that accompany the detailed description can be briefly described as follows.</p>
<?BRFSUM description="Brief Summary" end="tail"?>
<?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?>
<description-of-drawings>
<heading id="h-0005" level="1">BRIEF DESCRIPTION OF THE DRAWINGS</heading>
<p id="p-0012" num="0011"><figref idref="DRAWINGS">FIG. 1</figref> is a perspective view of a nasal delivery device designed according to this invention.</p>
<p id="p-0013" num="0012"><figref idref="DRAWINGS">FIG. 2</figref> is a side elevation view of the nasal delivery device of <figref idref="DRAWINGS">FIG. 1</figref>.</p>
<p id="p-0014" num="0013"><figref idref="DRAWINGS">FIG. 3</figref> is a side elevation view of the nasal delivery device of <figref idref="DRAWINGS">FIG. 1</figref> viewed from the one end.</p>
<p id="p-0015" num="0014"><figref idref="DRAWINGS">FIG. 4</figref> is a partial cross-sectional view of the nasal delivery device of <figref idref="DRAWINGS">FIG. 3</figref> taken along line <b>4</b>-<b>4</b>.</p>
<p id="p-0016" num="0015"><figref idref="DRAWINGS">FIG. 5</figref> is a cross-sectional view of the nasal delivery device of <figref idref="DRAWINGS">FIG. 2</figref> taken along line <b>5</b>-<b>5</b>.</p>
<p id="p-0017" num="0016"><figref idref="DRAWINGS">FIG. 6</figref> is an enlarged cross-sectional view of the spray nozzle of the nasal delivery device illustrating a two-component spray nozzle assembly having one-way valve features.</p>
<p id="p-0018" num="0017"><figref idref="DRAWINGS">FIG. 7</figref> is an enlarged cross-sectional view of the spray nozzle illustrating a snap-fit feature.</p>
<p id="p-0019" num="0018"><figref idref="DRAWINGS">FIG. 8</figref> is a side elevational view of an alternative embodiment of a nasal delivery device designed according to this invention.</p>
<p id="p-0020" num="0019"><figref idref="DRAWINGS">FIG. 9</figref> is a flow chart diagram schematically illustrating a method of filling a device designed according to this invention.</p>
</description-of-drawings>
<?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?>
<?DETDESC description="Detailed Description" end="lead"?>
<heading id="h-0006" level="1">DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS</heading>
<p id="p-0021" num="0020"><figref idref="DRAWINGS">FIGS. 1-6</figref> illustrate the nasal delivery device of the present invention generally designated <b>20</b> including a drug container such as a standard syringe and a separable spray nozzle <b>37</b> attachable thereto. The syringe has an elongated barrel <b>21</b> having an open proximal end <b>22</b>, a chamber <b>23</b> for retaining liquid and a tip portion <b>25</b> extending from a distal end <b>27</b> of the barrel <b>21</b>. A passageway <b>28</b> extends through the tip portion <b>25</b> between the chamber <b>23</b> and an opening in the end of the tip portion.</p>
<p id="p-0022" num="0021">For the purposes of this description, the term “distal end” is used to refer to the end furthest from the person holding the nasal delivery device and the term “proximal end” is meant to refer to the end closest to the holder of the nasal delivery device.</p>
<p id="p-0023" num="0022">A stopper <b>29</b> is slidably positioned in fluid-tight engagement inside barrel <b>21</b> and is connected to an elongate plunger rod <b>31</b> in a conventional manner. The plunger rod <b>31</b> projects proximally from the stopper <b>29</b> and extends outwardly from the open proximal end <b>22</b> of the barrel <b>21</b>. The plunger rod <b>31</b> is accessible outside of the proximal end of the barrel and is provided to move the stopper <b>29</b> along the barrel <b>21</b> to force liquid out of the chamber <b>23</b> through the passageway <b>28</b>. A disc-shaped plunger rod flange <b>32</b> on the proximal end of the plunger rod <b>31</b> provides a convenient structure for applying forces to move the plunger rod <b>31</b> with respect to the barrel <b>21</b>. The large surface area of the flange <b>32</b> reduces the pressure on a user's fingers while delivering the substance such as a drug, vaccine or the like through the nasal delivery device.</p>
<p id="p-0024" num="0023">A therapeutic liquid such as liquid substance <b>35</b> is contained within the chamber <b>23</b>. The syringe can be prefilled or manually filled by an end user as needed. An example method of prefilling is discussed below in connection with <figref idref="DRAWINGS">FIG. 9</figref>. In the event that the user fills the syringe, that should be completed before the spray nozzle <b>37</b> is in place.</p>
<p id="p-0025" num="0024">In order to deliver the liquid substance <b>35</b> to the nasal passage of a user, the separable spray nozzle <b>37</b> slides onto the tip <b>25</b> of the syringe <b>20</b>. The internal surface of the spray nozzle <b>37</b> defines a conduit or internal passage <b>39</b> that receives the tip portion <b>25</b> and is in fluid communication with the passageway <b>28</b> when placed on the tip portion <b>25</b> of the syringe. The spray nozzle <b>37</b> also includes a distal end <b>40</b> having a spray aperture <b>41</b> in fluid communication with passage <b>39</b>.</p>
<p id="p-0026" num="0025">The spray nozzle <b>37</b> preferably includes two main components; a generally rigid plastic cap <b>38</b> and a generally flexible valve <b>45</b>. The cap <b>38</b> preferably is constructed of a polymer, such as polypropylene, and is configured to be slidably mounted onto the tip portion <b>25</b> of the barrel <b>21</b> of the syringe. A conventional luer tip arrangement between the tip portion <b>25</b> and a cooperating opening <b>44</b> of the cap <b>38</b> secure the cap <b>38</b> in place.</p>
<p id="p-0027" num="0026">A variety of cap openings and tip configurations can be used. It is useful to use tip designs that differ from conventional syringes when it is important to ensure that a standard hypodermic needle will not be used with a syringe body intended for use with the spray nozzle <b>37</b> of the present invention.</p>
<p id="p-0028" num="0027">The valve <b>45</b> preferably is contained within the cap <b>38</b> between the tip portion <b>25</b> and the distal end <b>40</b> of the cap <b>38</b>. The valve <b>45</b> interacts with the internal surface of cap <b>38</b> to allow only pressurized liquid to flow distally through the spray aperture <b>41</b>. The valve <b>45</b> prevents unpressurized liquid in the chamber <b>23</b> from flowing through the aperture <b>41</b>. Therefore, a mist of liquid rather than a stream or drops are expelled from the outlet <b>41</b>.</p>
<p id="p-0029" num="0028">The valve in one preferred embodiment is a skirt valve having a circumferential skirt <b>46</b> that will partially collapse or move away from the internal sidewall under the force of pressurized liquid from the chamber <b>23</b> to allow the liquid to flow from the syringe through the spray aperture <b>41</b>. The skirt <b>46</b> collapses by moving away from the interior side wall of the cap <b>38</b> allowing liquid to pass through the gap, which is created by hydraulic pressure, between the skirt <b>46</b> and the cap <b>38</b>. Since the skirt <b>46</b> is normally biased into engagement with the internal sidewall and only flexes in one direction, it ensures that no fluid flows in a backward direction through the cap. A wide variety of materials such as natural rubber, synthetic rubber and thermoplastic elastomers are suitable for forming the flexible valve <b>45</b> with thermoplastic elastomers being preferred.</p>
<p id="p-0030" num="0029">The spray nozzle <b>37</b> preferably includes a flange <b>43</b> at a proximal end of the cap <b>38</b>. Flange <b>43</b> acts as a depth limiter to prevent over-insertion of the nozzle <b>37</b> into the nasal passage.</p>
<p id="p-0031" num="0030">As shown in <figref idref="DRAWINGS">FIG. 7</figref>, the spray nozzle <b>37</b> may be configured so that it may not be removed from the syringe. In this embodiment, the tip <b>25</b> of the syringe has a groove <b>60</b> that preferably extends circumferentially around the tip portion adjacent the syringe body. Cooperating opening <b>44</b> has a corresponding undercut <b>62</b> that forms a flange so that when the cap <b>38</b> is slid onto the tip <b>25</b>, a snap-fit between the flange and groove effectively permanently secures the nozzle <b>37</b> to the syringe. The valve <b>45</b> is not illustrated in <figref idref="DRAWINGS">FIG. 7</figref> for simplification. A valve preferably is included to ensure that a mist or spray is delivered into a nasal passage.</p>
<p id="p-0032" num="0031">In some instances, it is useful to permit some flow back into the syringe through the spray nozzle. For example, <figref idref="DRAWINGS">FIG. 7</figref> includes a modified valve <b>45</b>′ that has at least one passage <b>46</b><i>a </i>through the skirt <b>46</b>. This passage allows fluid to be drawn into the syringe when using an appropriately configured vial adapter.</p>
<p id="p-0033" num="0032">As best seen in <figref idref="DRAWINGS">FIGS. 2</figref>, <b>4</b> and <b>5</b>, a dosage limiter <b>47</b> can be employed. The limiter <b>47</b> partially surrounds the plunger rod <b>31</b> so that the limiter <b>47</b> will not fall off the plunger rod <b>31</b> under its own weight but may be forcibly removed from the plunger rod <b>31</b> without eliminating the ability of the nasal delivery device to deliver the substance from the chamber through the aperture <b>41</b>. The limiter <b>47</b> may be designed with a thin cross-section so that it will deflect and snap over the plunger rod <b>31</b> or the plunger rod <b>31</b> may be designed to deflect under the forces of the limiter <b>47</b> during attachment or removal. Alternatively, both elements may be designed to deflect partially during installation and removal of the limiter <b>47</b>. A finger tab portion <b>49</b> facilitates installation and removal. A plurality of ribs <b>50</b> provide a better grip.</p>
<p id="p-0034" num="0033">The limiter <b>47</b> is adapted to interact between a radially extending projection on the plunger rod <b>31</b> such as flange <b>32</b> and proximal end <b>22</b> of the barrel <b>21</b> which includes a barrel flange <b>26</b> to limit the distal motion of the plunger rod with respect to the barrel <b>21</b>. For example, the length of the limiter <b>47</b> can correspond to one-half of the volume of liquid substance in the chamber <b>23</b>, which proves useful to deliver equal doses into each nostril.</p>
<p id="p-0035" num="0034">In use, the nasal delivery device can be inserted into one nostril of the user while it is fully loaded such as illustrated in <figref idref="DRAWINGS">FIG. 4</figref>. Pressure on the plunger rod flange <b>22</b> in a distal direction (i.e., right to left according to the drawing) will cause the liquid substance <b>35</b> to flow through the passageway <b>28</b> into the conduit <b>39</b> of the cap <b>38</b>, deflecting the skirt portion <b>46</b> of the flexible valve <b>45</b>, and through the spray aperture <b>41</b>. The plunger rod <b>31</b> can be moved until further distal motion is prevented by contact of the plunger rod flange <b>32</b> with limiter <b>47</b> which, in turn, contacts barrel flange <b>26</b>. The plunger rod <b>31</b> can no longer be moved in a distal direction and approximately one-half of the liquid substance still remains in the syringe.</p>
<p id="p-0036" num="0035">The user then removes the nasal delivery device from one nostril, pulls the limiter <b>47</b> off the plunger rod <b>31</b> and prepares to deliver a dose to the other nostril. With the limiter <b>47</b> now removed, the nasal delivery device may now be placed so that the spray nozzle is in the other nostril and the remaining half of the liquid substance <b>35</b> may be delivered.</p>
<p id="p-0037" num="0036">An alternative embodiment nasal delivery device <b>55</b> is illustrated in <figref idref="DRAWINGS">FIG. 8</figref>. In this embodiment, the structure of the nasal delivery device is substantially similar to the nasal delivery device of the embodiment of <figref idref="DRAWINGS">FIGS. 1-7</figref>. Accordingly, substantially similar components that perform substantially similar functions will be numbered identically to the components of the embodiment of <figref idref="DRAWINGS">FIGS. 1-7</figref> except a suffix “a” will be used to identify those components in <figref idref="DRAWINGS">FIG. 8</figref>.</p>
<p id="p-0038" num="0037">In this alternate embodiment, the spray nozzle <b>37</b> preferably includes a generally resilient, elongate sleeve member <b>64</b> extending from the cap <b>38</b><i>a</i>. Elongate sleeve member <b>64</b> may be a unitary sleeve member that fully surrounds the syringe body or may include two finger-like portions <b>66</b>, as shown in <figref idref="DRAWINGS">FIG. 8</figref>. A sleeve flange <b>68</b> provides an increased surface area to aid a user in delivering the liquid from the syringe to the nasal passage. The increased surface area is more easily retained against an individual's index and fore fingers than the typical end <b>22</b><i>a </i>of the syringe body. Additionally, pressure from the individual's finger serves to maintain the nozzle <b>37</b> on the syringe.</p>
<p id="p-0039" num="0038">The embodiment of <figref idref="DRAWINGS">FIG. 8</figref> preferably includes a valve member in the cap portion <b>38</b><i>a </i>as described above to ensure a spray or mist delivery. The adapter <b>37</b><i>a </i>can include the snap fit shown in <figref idref="DRAWINGS">FIG. 7</figref>.</p>
<p id="p-0040" num="0039">There are several advantages provided by the present invention. The inventive arrangement having a nasal sprayer adapter can be used to deliver the substance that is targeted for nasal delivery but is not liquid-stable and, therefore, needs to be stored in powder or lyophilized form in a separate, appropriate vial. Other nasal delivery device devices that do not have a cap like that of this invention cannot accommodate such substances.</p>
<p id="p-0041" num="0040">Less water vapor is lost from a syringe that works with the inventive adapter since the plastic cap need not be permanently attached to the syringe prior to use. Additionally the likelihood for pressure valve activation during plunger rod assembly and handling is lessened since the spray nozzle need not be attached to the syringe until it is ready for use. Furthermore, stability testing regarding compatibility issues is simplified since the plastic spray nozzle does not interfere with the liquid substance over a long period of time.</p>
<p id="p-0042" num="0041">The advantages provided by this invention render it more useful for use with prefilled syringes. One method of prefilling syringes to be used as a nasal delivery device is schematically shown in flow chart form in <figref idref="DRAWINGS">FIG. 9</figref>.</p>
<p id="p-0043" num="0042">A supply of syringe barrels <b>200</b> includes the desired form of syringe, such as those illustrated and discussed above. A locally controlled environment <b>202</b> preferably is maintained in a known manner. The locally controlled environment <b>202</b> preferably is situated to immediately accept the syringes without requiring any intermediate cleaning or sterilizing steps between the supply <b>200</b> and the environment <b>202</b>.</p>
<p id="p-0044" num="0043">In one example, the syringe barrels are washed with air at <b>204</b> to remove any particulates from the syringes. The syringes preferably are then coated at <b>206</b> with a lubricant such as a lubricating silicone oil on the inner surface. The lubricant facilitates moving the stopper <b>29</b> and plunger rod <b>31</b> through the syringe during actual use of the device.</p>
<p id="p-0045" num="0044">The end of syringes that eventually receive the spray nozzle may be capped with a tip cap within the environment <b>202</b>. In one example, tip caps are supplied at <b>208</b>. The tip caps are air washed at <b>210</b>. The cleaned tip caps and syringe barrels are conveyed to an assembly device <b>212</b> where the tip caps are secured onto the syringes. The syringe barrel assemblies are then conveyed to a filling station <b>214</b> to be filled with the desired substance.</p>
<p id="p-0046" num="0045">Once filled as desired, the stoppers <b>29</b> are inserted into the open end of the syringes at <b>220</b>. Prior to inserting the stoppers <b>29</b>, they preferably are assembled with the plunger rods <b>31</b> at <b>222</b> and lubricated at <b>224</b> with a conventional lubricant in a known manner. The assembled, filled syringes preferably are inspected at <b>226</b> for defects and discharged from the locally controlled environment.</p>
<p id="p-0047" num="0046">The syringes typically will be sterilized at <b>230</b> and packaged at <b>232</b> into individual packages or into bulk packaging depending on the needs of a particular situation. Suitable sterilization techniques are known and will be chosen by those skilled in the art depending on the needs of a particular situation or to accommodate the properties of a given substance. Sterilizing a device designed according to this invention can be completed before or after packaging.</p>
<p id="p-0048" num="0047">Variations of the filling steps are within the scope of this invention. For example, the stopper can be inserted first, then fill the syringe, followed by applying a tip cap.</p>
<p id="p-0049" num="0048">The actual insertion of the desired substance can be accomplished in any of several known manners. Example filling techniques are disclosed in U.S. Pat. No. 5,620,425 to Hefferman et al.; U.S. Pat. No. 5,597,530 to Smith et al.; U.S. Pat. No. 5,537,042 to DeHaen; U.S. Pat. No. 5,531,255 to Vacca; U.S. Pat. No. 5,519,984 to Veussink et al.; U.S. Pat. No. 5,373,684 to Veussink et al.; U.S. Pat. No. 5,265,154 to Liebert et al.; U.S. Pat. No. 5,287,983 to Liebert et al.; and U.S. Pat. No. 4,718,463 to Jurgens, Jr. et al., each of which is incorporated by reference into this specification.</p>
<p id="p-0050" num="0049">The description just given is exemplary rather than limiting in nature. Variations and modifications may become apparent to those skilled in the art that do no necessarily depart from the basis of this invention. The scope of legal protection given to this invention can only be determined by studying the following claims.</p>
<?DETDESC description="Detailed Description" end="tail"?>
</description>
<us-claim-statement>What is claimed is:</us-claim-statement>
<claims id="claims">
<claim id="CLM-00001" num="00001">
<claim-text>1. A nasal delivery device for delivering liquid substances including drug and vaccines to a nasal passage, comprising:
<claim-text>a syringe having a rigid body with an outlet opening at one end;</claim-text>
<claim-text>a separate spray nozzle including:</claim-text>
<claim-text>a rigid cap body having an internal passage extending between an inlet opening at one end and a spray aperture at a distal end, said cap body being sealingly secured to the syringe body adjacent the outlet opening; and</claim-text>
<claim-text>a valve having a skirt portion surrounding a base, the skirt portion movable from a first position in contact with an internal wall of the internal passage to a second position spaced from the internal wall of the internal passage when substances pressurized at or above a minimum threshold pressure flows from the inlet opening, so that only pressurized substances at or above the minimum pressure threshold level flow through the passage into and out of the spray aperture and so that substances below the minimum threshold pressure are prevented from flowing through the spray aperture, wherein the valve is configured to operate in two directions and wherein the valve defines at least one passage through the skirt portion allowing fluid to be drawn through the valve and into the syringe.</claim-text>
</claim-text>
</claim>
<claim id="CLM-00002" num="00002">
<claim-text>2. The device of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the syringe includes a groove formed on an exterior surface near the outlet opening and the cap body includes a corresponding projection in the inlet opening that is at least partially received by the groove.</claim-text>
</claim>
<claim id="CLM-00003" num="00003">
<claim-text>3. The device of <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the projection is sufficiently rigid such that the cap body is fixedly secured to the syringe when the projection is received by the groove precluding subsequent removal of the spray nozzle.</claim-text>
</claim>
<claim id="CLM-00004" num="00004">
<claim-text>4. The device of <claim-ref idref="CLM-00001">claim 1</claim-ref>, wherein the cap includes a radially outward projecting flange for preventing over-insertion of the nozzle into the nasal passage.</claim-text>
</claim>
<claim id="CLM-00005" num="00005">
<claim-text>5. The device of <claim-ref idref="CLM-00001">claim 1</claim-ref>, whereupon the syringe includes an elongated barrel that defines a chamber and said chamber prefilled with at least one substance to be nasally delivered.</claim-text>
</claim>
</claims>
</us-patent-grant>
